Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Cancer Discov. 2021 Mar 16;11(8):2032–2049. doi: 10.1158/2159-8290.CD-20-0242

Figure 3: CD72 is a highly-abundant cell surface marker in Diffuse Large B Cell Lymphoma.

Figure 3:

(a) Plot comparing the log2 transcript abundance of CD22, CD72, and CD19 by microarray analysis of a DLBCL patient cohort (GSE12195, n=73). (b) CD72 transcript abundance by microarray analysis of ABC and GCB subtypes of DLBCL patient samples (GSE11318, n=203 and GSE23967, n=69). (c) Quantification of CD72 abundance by immunohistochemistry (IHC) staining of banked DLBCL patient samples (total, n=28) displayed by ABC or GCB subtype. (d) Representative raw images of CD72 staining intensity by IHC of two different DLBCL patient samples.